Editas Medicine (EDIT) Capital Leases (2016 - 2018)

Editas Medicine (EDIT) has reported Capital Leases for 3 consecutive years, with $32.4 million the latest figure, recorded in Q4 2018.

• In Q4 2018, Capital Leases fell 3.03% year-over-year to $32.4 million; the TTM figure through Dec 2018 stood at $32.4 million (down 3.03% YoY), while the FY2018 annual figure was $32.4 million, down 3.03% from the prior year.
• Capital Leases retreated to $32.4 million in Q4 2018 per EDIT's latest filing, from $32.7 million in the prior quarter.
• Across five years, Capital Leases topped out at $35.1 million in Q4 2016 and bottomed at $11.6 million in Q1 2016.
• Historically, Capital Leases has averaged $30.6 million across 3 years, with a median of $33.1 million in 2018.
• On a YoY basis, Capital Leases climbed as much as 191.26% in 2017 and fell as far as 4.74% in 2017.
• Editas Medicine's Capital Leases stood at $35.1 million in 2016, then declined by 4.74% to $33.4 million in 2017, then dropped by 3.03% to $32.4 million in 2018.
• Business Quant data shows EDIT's Capital Leases at $32.4 million in Q4 2018, $32.7 million in Q3 2018, and $32.9 million in Q2 2018.